Prognostic value of neutrophil-to-lymphocyte ratio in patients with metastatic renal cell carcinoma treated with first-line and subsequent second-line targeted therapy: A proposal of the modified-IMDC risk model.
暂无分享,去创建一个
K. Nakagawa | M. Oya | M. Oyama | R. Mizuno | K. Ito | T. Asano | S. Mikami | T. Momma | N. Tanaka | Y. Yasumizu | Y. Miyazaki | A. Masunaga | M. Hagiwara | Yujiro Ito | S. Shirotake | T. Masuda | K. Kanao